*

Penny Stock DD

Tag: AVII

NASDAQ Losers Of The Day: (AVII, CTIC)

April 15, 2011
[del.icio.us] [Digg] [Faves] [LinkedIn] [Reddit] [StumbleUpon] [Technorati] More »

AVI BioPharma, Inc. (NASDAQ:AVII) went down by 3.49% to close at $1.66 with overall traded volume of 1.33 million shares in the last trading day. The share price is likely to move by 1.18 times against 1 point change in market index.

Cell Therapeutics, Inc. (NASDAQ:CTIC) reported the fall of 2.63% and closed at $0.37 whereas total traded volume stood at 5.60 million shares for the day. The share price is highly reactive to market index as its beta value stands at 5.82 times till its last trading session.

By,

(Read the Rest of the Article…)

: Stock Alerts
: , , , , ,

Results at the end of the day on some of my Picks

September 8, 2010
[del.icio.us] [Digg] [Faves] [LinkedIn] [Reddit] [StumbleUpon] [Technorati] More »

ARMH UP  0.97 CENTS

AVII UP 0.02 CENTS

CIEN UP 68 CENTS

JASO UP 51 CENTS

4 for 4 on these and you wonder about the VIP service.

Regards,

Don

: Stock Picks
: , , ,

Stock moving on the open

September 8, 2010
[del.icio.us] [Digg] [Faves] [LinkedIn] [Reddit] [StumbleUpon] [Technorati] More »

 ARMH, AVII, CIEN, JASO

Regards,

Don

: Stock Picks
: , , ,

Into next week, let’s watch the following stocks

September 6, 2010
[del.icio.us] [Digg] [Faves] [LinkedIn] [Reddit] [StumbleUpon] [Technorati] More »

Major Price jumps at NASDAQ healthcare sector: (ARNA, AVII, CTIC, SNSS, SOMX)

Many of these stocks have been my Picks and they continue to to well. If we continue into any kind of rally, we could see a Major pop in one or more of  these stocks. Healthcare sector stocks have been particularly strong in August.

Regards,

Don

: Stock Picks
: , , , ,

Second Pick for Monday and the week ahead.

August 1, 2010
[del.icio.us] [Digg] [Faves] [LinkedIn] [Reddit] [StumbleUpon] [Technorati] More »
Ticker Symbol: AVII
Exchange: NASDAQ
Contact Info: One SW Columbia Street
Portland OR 97258
503 227-0554
CEO / President: Leslie Hudson Ph.D.
Industry/Sector: Medical – Biomedical
SIC Code: SIC-2834 Pharmaceutical Preparations
Description: AVI BioPharma develops therapeutic products for the treatment of life-threatening diseases using third-generation NEUGENE antisense drugs and ESPRIT exon skipping technology. AVI’s lead NEUGENE antisense compound is designed to target cell proliferation disorders, including cardiovascular restenosis. In addition to targeting specific genes in the body, AVI’s antiviral program uses NEUGENE antisense compounds to combat disease by targeting single-stranded RNA viruses, including West Nile virus, hepatitis C virus, dengue virus, Ebola virus and influenza A virus. AVI’s NEUGENE-based ESPRIT technology will initially be applied to potential treatments for Duchenne muscular dystrophy.

Regards,

Don

: Stock Picks
:
Bombax Theme designed by itx
Performance Optimization WordPress Plugins by W3 EDGE